Cincinnati Children's is doing a research study, sometimes known as a clinical trial or clinical study, to learn if an experimental respiratory syncytial virus, or RSV vaccine is safe and could offer protection from serious RSV disease. RSV is a common respiratory virus that can be very serious for infants and older adults. It is one of the leading causes of hospitalization for infants.
Your child may be eligible if they are
Your child will:
You will complete a symptom diary to record any symptoms your child/adolescent may have, the evening after receiving the trial vaccination and for 6 days after receiving the trial vaccination.
You will be given a consent form that thoroughly explains the details of the study. A member of the study staff will review the consent form with you and will answer all of your questions.
Your infant/child may or may not personally benefit from their participation in this trial. However, by taking part, your infant/child will help to provide new scientific information that will contribute to the development of RSV vaccines.
Possible risks and discomforts will be discussed with you prior to the start of the study.
Participants will receive up to $365 for time and effort to complete the study.
https://redcap.research.cchmc.org/surveys/?s=D9LXPACXJLPWPDEN
Or contact:
The Vaccine Research Center at Cincinnati Children’s
513-636-7699
VaccineResearch@cchmc.org
Cincinnati Children’s Hospital Medical Center
3333 Burnet Ave.
Cincinnati, OH 45229-3039
Grant Paulsen, MD
Infectious Diseases
Cincinnati Children’s Hospital Medical Center